On January 11, 2024, Artisight, Inc. closed the transaction. The company has amended the terms of the transaction.The company has raised $42 million in an oversubscribed round of funding. The transaction included participation from new strategic and client health system investors participated in the round, as well as full participation from Series A investors including NVIDIA Corporation.